These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18672491)

  • 21. Medical device regulation: an introduction for the practicing physician.
    Maisel WH
    Ann Intern Med; 2004 Feb; 140(4):296-302. PubMed ID: 14970153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical Devices; Gastroenterology-Urology Devices; Classification of the Metallic Biliary Stent System for Benign Strictures. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Jul; 81(134):45229-32. PubMed ID: 27411238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion.
    Menon K; Romagnuolo J; Barkun AN
    Am J Gastroenterol; 2001 May; 96(5):1435-40. PubMed ID: 11374679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A US Multicenter Study of Safety and Efficacy of Fully Covered Self-Expandable Metallic Stents in Benign Extrahepatic Biliary Strictures.
    Saxena P; Diehl DL; Kumbhari V; Shieh F; Buscaglia JM; Sze W; Kapoor S; Komanduri S; Nasr J; Shin EJ; Singh V; Lennon AM; Kalloo AN; Khashab MA
    Dig Dis Sci; 2015 Nov; 60(11):3442-8. PubMed ID: 25850628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices.
    Sutherell JS; Hirsch R; Beekman RH
    Congenit Heart Dis; 2010; 5(1):2-7. PubMed ID: 20136851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical devices--balancing regulation and innovation.
    Curfman GD; Redberg RF
    N Engl J Med; 2011 Sep; 365(11):975-7. PubMed ID: 21830959
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastrointestinal and biliary stents.
    Chun HJ; Kim ES; Hyun JJ; Kwon YD; Keum B; Kim CD
    J Gastroenterol Hepatol; 2010 Feb; 25(2):234-43. PubMed ID: 20136988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceuticals and medical devices: medical devices.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-38. PubMed ID: 22403842
    [No Abstract]   [Full Text] [Related]  

  • 30. The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI.
    Price MJ; Teirstein PS
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):500-4. PubMed ID: 18814224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
    Brodie BR; Stuckey T; Downey W; Humphrey A; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Smith H; Edmunds J; Varanasi J; Simonton CA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):405-14. PubMed ID: 19463338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.
    Bleicher EW
    Food Drug Law J; 2009; 64(3):531-64. PubMed ID: 19999642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction].
    Daróczi T; Bor R; Fábián A; Szabó E; Farkas K; Bálint A; Czakó L; Rutka M; Szűcs M; Milassin Á; Molnár T; Szepes Z
    Orv Hetil; 2016 Feb; 157(7):268-74. PubMed ID: 26853728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U.S. medical device reporting: who is responsible?
    Donawa M
    Med Device Technol; 2005 Apr; 16(3):27-9. PubMed ID: 15871421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceuticals and medical devices: medical devices.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
    [No Abstract]   [Full Text] [Related]  

  • 37. Endoscopic management of bile duct injury after hepatobiliary tract surgery: a comprehensive review.
    Luigiano C; Iabichino G; Mangiavillano B; Eusebi LH; Arena M; Consolo P; Morace C; Fagoonee S; Barabino M; Opocher E; Pellicano R
    Minerva Chir; 2016 Dec; 71(6):398-406. PubMed ID: 27589348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmarket evaluation of breakthrough technologies.
    Rao SV; Califf RM; Kramer JM; Peterson ED; Gross TP; Pepine CJ; Williams DO; Donohoe D; Waksman R; Mehran R; Krucoff MW
    Am Heart J; 2008 Aug; 156(2):201-8. PubMed ID: 18657647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The saga of Poly Implant Prosthese breast implants.
    Heneghan C
    BMJ; 2012 Jan; 344():e306. PubMed ID: 22236799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.